Since NF1 patients have a 10% lifetime chance of being ultimately diagnosed with MPNST and the incidence of MPNST is very low in the general population, this leads to the general idea that NF1 patients, harboring an NF1+/− microenvironment, are more susceptible to this cancer development. Here, NF1 is linked to cancer.